Truncated NS1 Influenza A Virus Induces a Robust Antigen-Specific Tissue-Resident T-Cell Response and Promotes Inducible Bronchus-Associated Lymphoid Tissue Formation in Mice

Background: Influenza viruses with truncated NS1 proteins show promise as viral vectors and candidates for mucosal universal influenza vaccines. These mutant NS1 viruses, which lack the N-terminal half of the NS1 protein (124 a.a.), are unable to antagonise the innate immune response. This creates a...

Full description

Saved in:
Bibliographic Details
Main Authors: Anna-Polina Shurygina, Marina Shuklina, Olga Ozhereleva, Ekaterina Romanovskaya-Romanko, Sofia Kovaleva, Andrej Egorov, Dmitry Lioznov, Marina Stukova
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/13/1/58
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587366547587072
author Anna-Polina Shurygina
Marina Shuklina
Olga Ozhereleva
Ekaterina Romanovskaya-Romanko
Sofia Kovaleva
Andrej Egorov
Dmitry Lioznov
Marina Stukova
author_facet Anna-Polina Shurygina
Marina Shuklina
Olga Ozhereleva
Ekaterina Romanovskaya-Romanko
Sofia Kovaleva
Andrej Egorov
Dmitry Lioznov
Marina Stukova
author_sort Anna-Polina Shurygina
collection DOAJ
description Background: Influenza viruses with truncated NS1 proteins show promise as viral vectors and candidates for mucosal universal influenza vaccines. These mutant NS1 viruses, which lack the N-terminal half of the NS1 protein (124 a.a.), are unable to antagonise the innate immune response. This creates a self-adjuvant effect enhancing heterologous protection by inducing a robust CD8+ T-cell response together with immunoregulatory mechanisms. However, the effects of NS1 modifications on T-follicular helper (Tfh) and B-cell responses remain less understood. Methods: C57bl/6 mice were immunised intranasally with 10 μL of either an influenza virus containing a truncated NS1 protein (PR8/NS124), a cold-adapted influenza virus with a full-length NS1 (caPR8/NSfull), or a wild-type virus (PR8/NSfull). Immune responses were assessed on days 8 and 28 post-immunisation by flow cytometry, ELISA, and HAI assay. Results: In this study, we demonstrate that intranasal immunisation with PR8/NS124 significantly increases tissue-resident CD4+ and CD8+ T cells in the lungs and activates Tfh cells in regional lymph nodes as early as day 8 post-immunisation. These effects are not observed in mice immunised with caPR8/NSfull or PR8/NSfull. Notably, PR8/NS124 immunisation also leads to the development of inducible bronchus-associated lymphoid tissue (iBALT) in the lungs by day 28, characterised by the presence of antigen-specific Tfh cells and GL7+Fas+ germinal centre B cells. Conclusions: Our findings further underscore the potential of NS1-truncated influenza viruses to drive robust mucosal immune responses and enhance vaccine efficacy.
format Article
id doaj-art-84f4890179b343d2aad11ccc998f16ad
institution Kabale University
issn 2076-393X
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj-art-84f4890179b343d2aad11ccc998f16ad2025-01-24T13:51:48ZengMDPI AGVaccines2076-393X2025-01-011315810.3390/vaccines13010058Truncated NS1 Influenza A Virus Induces a Robust Antigen-Specific Tissue-Resident T-Cell Response and Promotes Inducible Bronchus-Associated Lymphoid Tissue Formation in MiceAnna-Polina Shurygina0Marina Shuklina1Olga Ozhereleva2Ekaterina Romanovskaya-Romanko3Sofia Kovaleva4Andrej Egorov5Dmitry Lioznov6Marina Stukova7Smorodintsev Research Institute of Influenza, The Ministry of Health of the Russian Federation, Saint-Petersburg 197022, RussiaSmorodintsev Research Institute of Influenza, The Ministry of Health of the Russian Federation, Saint-Petersburg 197022, RussiaSmorodintsev Research Institute of Influenza, The Ministry of Health of the Russian Federation, Saint-Petersburg 197022, RussiaSmorodintsev Research Institute of Influenza, The Ministry of Health of the Russian Federation, Saint-Petersburg 197022, RussiaSmorodintsev Research Institute of Influenza, The Ministry of Health of the Russian Federation, Saint-Petersburg 197022, RussiaSmorodintsev Research Institute of Influenza, The Ministry of Health of the Russian Federation, Saint-Petersburg 197022, RussiaSmorodintsev Research Institute of Influenza, The Ministry of Health of the Russian Federation, Saint-Petersburg 197022, RussiaSmorodintsev Research Institute of Influenza, The Ministry of Health of the Russian Federation, Saint-Petersburg 197022, RussiaBackground: Influenza viruses with truncated NS1 proteins show promise as viral vectors and candidates for mucosal universal influenza vaccines. These mutant NS1 viruses, which lack the N-terminal half of the NS1 protein (124 a.a.), are unable to antagonise the innate immune response. This creates a self-adjuvant effect enhancing heterologous protection by inducing a robust CD8+ T-cell response together with immunoregulatory mechanisms. However, the effects of NS1 modifications on T-follicular helper (Tfh) and B-cell responses remain less understood. Methods: C57bl/6 mice were immunised intranasally with 10 μL of either an influenza virus containing a truncated NS1 protein (PR8/NS124), a cold-adapted influenza virus with a full-length NS1 (caPR8/NSfull), or a wild-type virus (PR8/NSfull). Immune responses were assessed on days 8 and 28 post-immunisation by flow cytometry, ELISA, and HAI assay. Results: In this study, we demonstrate that intranasal immunisation with PR8/NS124 significantly increases tissue-resident CD4+ and CD8+ T cells in the lungs and activates Tfh cells in regional lymph nodes as early as day 8 post-immunisation. These effects are not observed in mice immunised with caPR8/NSfull or PR8/NSfull. Notably, PR8/NS124 immunisation also leads to the development of inducible bronchus-associated lymphoid tissue (iBALT) in the lungs by day 28, characterised by the presence of antigen-specific Tfh cells and GL7+Fas+ germinal centre B cells. Conclusions: Our findings further underscore the potential of NS1-truncated influenza viruses to drive robust mucosal immune responses and enhance vaccine efficacy.https://www.mdpi.com/2076-393X/13/1/58influenzaintranasal immunizationtruncated NS1 proteinLAIVuniversal influenza vaccinetissue-resident T cells
spellingShingle Anna-Polina Shurygina
Marina Shuklina
Olga Ozhereleva
Ekaterina Romanovskaya-Romanko
Sofia Kovaleva
Andrej Egorov
Dmitry Lioznov
Marina Stukova
Truncated NS1 Influenza A Virus Induces a Robust Antigen-Specific Tissue-Resident T-Cell Response and Promotes Inducible Bronchus-Associated Lymphoid Tissue Formation in Mice
Vaccines
influenza
intranasal immunization
truncated NS1 protein
LAIV
universal influenza vaccine
tissue-resident T cells
title Truncated NS1 Influenza A Virus Induces a Robust Antigen-Specific Tissue-Resident T-Cell Response and Promotes Inducible Bronchus-Associated Lymphoid Tissue Formation in Mice
title_full Truncated NS1 Influenza A Virus Induces a Robust Antigen-Specific Tissue-Resident T-Cell Response and Promotes Inducible Bronchus-Associated Lymphoid Tissue Formation in Mice
title_fullStr Truncated NS1 Influenza A Virus Induces a Robust Antigen-Specific Tissue-Resident T-Cell Response and Promotes Inducible Bronchus-Associated Lymphoid Tissue Formation in Mice
title_full_unstemmed Truncated NS1 Influenza A Virus Induces a Robust Antigen-Specific Tissue-Resident T-Cell Response and Promotes Inducible Bronchus-Associated Lymphoid Tissue Formation in Mice
title_short Truncated NS1 Influenza A Virus Induces a Robust Antigen-Specific Tissue-Resident T-Cell Response and Promotes Inducible Bronchus-Associated Lymphoid Tissue Formation in Mice
title_sort truncated ns1 influenza a virus induces a robust antigen specific tissue resident t cell response and promotes inducible bronchus associated lymphoid tissue formation in mice
topic influenza
intranasal immunization
truncated NS1 protein
LAIV
universal influenza vaccine
tissue-resident T cells
url https://www.mdpi.com/2076-393X/13/1/58
work_keys_str_mv AT annapolinashurygina truncatedns1influenzaavirusinducesarobustantigenspecifictissueresidenttcellresponseandpromotesinduciblebronchusassociatedlymphoidtissueformationinmice
AT marinashuklina truncatedns1influenzaavirusinducesarobustantigenspecifictissueresidenttcellresponseandpromotesinduciblebronchusassociatedlymphoidtissueformationinmice
AT olgaozhereleva truncatedns1influenzaavirusinducesarobustantigenspecifictissueresidenttcellresponseandpromotesinduciblebronchusassociatedlymphoidtissueformationinmice
AT ekaterinaromanovskayaromanko truncatedns1influenzaavirusinducesarobustantigenspecifictissueresidenttcellresponseandpromotesinduciblebronchusassociatedlymphoidtissueformationinmice
AT sofiakovaleva truncatedns1influenzaavirusinducesarobustantigenspecifictissueresidenttcellresponseandpromotesinduciblebronchusassociatedlymphoidtissueformationinmice
AT andrejegorov truncatedns1influenzaavirusinducesarobustantigenspecifictissueresidenttcellresponseandpromotesinduciblebronchusassociatedlymphoidtissueformationinmice
AT dmitrylioznov truncatedns1influenzaavirusinducesarobustantigenspecifictissueresidenttcellresponseandpromotesinduciblebronchusassociatedlymphoidtissueformationinmice
AT marinastukova truncatedns1influenzaavirusinducesarobustantigenspecifictissueresidenttcellresponseandpromotesinduciblebronchusassociatedlymphoidtissueformationinmice